Douglas Hanahan

Douglas Hanahan

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Douglas Hanahan

Swiss Institute for Experimental Cancer Research (ISREC), EPFL, Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Cancer Discovery
Verified
Journal Article
Closed access
PDF file
DHDouglas Hanahan
Douglas Hanahan
The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. Significance: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of “big data” about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine.

1 March 2012 in Cancer Cell
Verified
Journal Article
Closed access
DHDouglas Hanahan
Douglas Hanahan
LCLisa M. Coussens
Lisa M. Coussens

14 April 2013 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
Anguraj SadanandamAnguraj Sadanandam
Anguraj Sadanandam
CLCostas Lyssiotis
Costas Lyssiotis
KHKrisztian Homicsko
Krisztian Homicsko
ECEric A Collisson
Eric A Collisson
WGWilliam J Gibb
William J Gibb
DHDouglas Hanahan
Douglas Hanahan

28 March 2024 in Cell
Verified
Journal Article
Closed access
CSCharles Swanton
Charles Swanton
EBElsa Bernard
Elsa Bernard
CAChris Abbosh
Chris Abbosh
FAFabrice André
Fabrice André
JAJohan Auwerx
Johan Auwerx
DHDouglas Hanahan
Douglas Hanahan

18 September 2019 in Nature
Verified
Journal Article
Closed access
PDF file
QZQiqun Zeng
Qiqun Zeng
IMIacovos P. Michael
Iacovos P. Michael
PZPeng Zhang
Peng Zhang
SSSadegh Saghafinia
Sadegh Saghafinia
GKGraham Knott
Graham Knott
DHDouglas Hanahan
Douglas Hanahan

13 March 2023 in Cancer Cell
Verified
Journal Article
Open access
DHDouglas Hanahan
Douglas Hanahan
MMMichelle Monje
Michelle Monje
The mechanisms underlying the multistep process of tumorigenesis can be distilled into a logical framework involving the acquisition of functional capabilities, the so-called hallmarks of cancer, which are collectively envisaged to be necessary for malignancy. These capabilities, embodied both in transformed cancer cells as well as in the heterotypic accessory cells that together constitute the tumor microenvironment (TME), are conveyed by certain abnormal characteristics of the cancerous phenotype. This perspective discusses the link between the nervous system and the induction of hallmark capabilities, revealing neurons and neuronal projections (axons) as hallmark-inducing constituents of the TME. We also discuss the autocrine and paracrine neuronal regulatory circuits aberrantly activated in cancer cells that may constitute a distinctive "enabling" characteristic contributing to the manifestation of hallmark functions and consequent cancer pathogenesis.